Table 1

Definitions of remission according to clinical, serological and therapeutic status allowed

	Disease activity			Treatment
	SLEDAI-2K		PGA	PDN	Antimalarials, biologics, immunosuppressants*
	Clinical	Serological	PGA	PDN	Antimalarials, biologics, immunosuppressants*
PDN ≤5 mg/day	Regardless	Regardless	Regardless	≤5 mg/day	Regardless
PGA <0.5	Regardless	Regardless	<0.5	Regardless	Regardless
cSLEDAI=0	0	Regardless	Regardless	Regardless	Regardless
PDN ≤5 mg/day plus PGA <0.5	Regardless	Regardless	<0.5	≤5 mg/day	Regardless
cSLEDAI=0 plus PGA <0.5	0	Regardless	<0.5	Regardless	Regardless
cSLEDAI=0 plus PDN ≤5 mg/day	0	Regardless	Regardless	≤5 mg/day	Regardless
cSLEDAI=0 plus PDN ≤5 mg/day plus PGA <0.5	0	Regardless	<0.5	≤5 mg/day	Regardless

*Stable well-tolerated doses.
cSLEDAI, clinical systemic lupus erythematosus Disease Activity Index 2000; PDN, prednisone equivalent; PGA, physician global assessment.